Paresthesia Treatment Market: Overview
Paresthesia is a neurological disorder. It is characterized by an abnormal and spontaneous sensation, wherein people feel a painless sensation of tingling, numbness, burning, itching, or prickling. It can also be described as a skin-crawling sensation or pins-and-needles. Paresthesia often occurs in the fingers, toes, hands, and feet; however, it can also affect other parts of the body. Paresthesia can be caused by nerve irritation, neurological disorders, hyperventilation, dehydration, neuropathy migraines, and heavy metal poisoning. Major causes of the disorder are hyperventilation syndrome, vitamin deficiency, and use of anesthesia. The various types of paresthesia are transient ischemic attack (TIA), hyperventilation syndrome, obdormition, whiplash, panic attack, and seizures. It can occur due to various reasons such as sitting crossed legs for a long time and sleeping for a long time with arm twisted under the hands. In worst cases, the symptoms can last for a lifetime and become chronic. Moreover, diseases such as cancer, arthritis, and diabetes increase the risk of paresthesia.
Paresthesia Treatment Market: Key Trends
The global paresthesia treatment market is driven by increase in incidence of diseases such as cancer, diabetes, arthritis, and other chronic diseases, surge in geriatric population, changing lifestyle, poor diet, and rise in prevalence of paresthesia. Additionally, lack of proper diet & exercise, favorable support from government for research & development, and excess smoking and alcohol consumption are projected to fuel the growth of the global paresthesia treatment market during forecast period. However, longer period required for drug approval and stringent regulatory rules are anticipated to act as restraints of the market.
Paresthesia Treatment Market: Segmentation
The global paresthesia treatment market can be segmented based on disease type, treatment type, and distribution channel. In terms of disease type, the market can be bifurcated into acute paresthesia and chronic paresthesia. Based on treatment type, the global paresthesia treatment market can be categorized into anticonvulsants, immunosuppressant, antivirals, topical creams, and others. Immunosuppressants include intravenous gamma globulin, prednisone, and others. Topical creams comprise prilocaine, lidocaine, and others. In terms of distribution channel, the market can be classified into hospitals, clinics, and diagnostic centers.
Paresthesia Treatment Market: Regional Analysis
In terms of region, the global paresthesia treatment market can be segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America is projected to lead the global paresthesia treatment market during the forecast period. The region’s dominance is attributed to large population with cancer and neurological disorders such as dementia, Alzheimer’s disease, and metabolic diseases. According to the Centers for Disease Control and Prevention (CDC), in 2015, more than 30 million people in the U.S. had diabetes and about 1.5 million new cases were diagnosed among adults aged 18 years or older. Furthermore, high health care expenditure and favorable government support for research & development contribute to the growth of the market in North America. Europe is anticipated to be the second largest market, followed by Asia Pacific. Asia Pacific is the fastest growing market for paresthesia treatment, as companies focus on exploiting the opportunities presented by the region and expanding presence.
Paresthesia Treatment Market: Competitive Landscape
Key players operating in the global paresthesia treatment market are Boston Scientific Corporation, EnteroMedics, Inc., Baxter, Bio-Medical Research Ltd., GlaxoSmithKline plc, St. Jude Medical, LLC, Nevro Corp., Cyberonics, Inc., Stimwave LLC, and Omron Healthcare, Inc. The market is highly fragmented, with the presence of large number of international players and local players. Local players are focusing on innovation and cost reduction and to ensure sustainability in the global paresthesia treatment market. Furthermore, some of the global players are adopting various strategies such as partnerships and collaborations with other companies to expand market share.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.